Cargando…

Clinical significance of serum interleukin‐8 and soluble tumor necrosis factor‐like weak inducer of apoptosis levels in patients with diabetic nephropathy

AIMS/INTRODUCTION: Recent studies suggest that chronic inflammatory responses are important in the development of diabetic nephropathy (DN). Various inflammatory and angiogenesis molecules affect the pathogenesis and progression of DN. Inflammation damages the microcirculation and causes kidney dama...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shu‐yan, Chen, Jie, Li, Yong‐feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123032/ https://www.ncbi.nlm.nih.gov/pubmed/29489069 http://dx.doi.org/10.1111/jdi.12828

Ejemplares similares

Serum tumor necrosis factor-like weak inducer of apoptosis levels are elevated in schizophrenia
por: Kiliç, Faruk, et al.
Publicado: (2020)

The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study
por: Yuksel, Mahmut, et al.
Publicado: (2016)

The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients
por: Ates, Ihsan, et al.
Publicado: (2014)

The significance of serum levels of soluble interleukin-2 receptor in patients undergoing maintenance hemodialysis
por: Chen, Xiaohong, et al.
Publicado: (2020)

Tumor Necrosis Factor-like Weak Inducer of Apoptosis: A Novel Serum Marker in Patients with Severe Alopecia
por: Al Taweel, Abdul-Aziz Ibrahim, et al.
Publicado: (2019)

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2010)

Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.
por: Kart, Levent, et al.
Publicado: (2003)

Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy
por: Kim, Yong Chul, et al.
Publicado: (2018)

Serum levels of tumor necrosis factor-alpha, interleukin-6 and interleukin-8 are not increased in dyspeptic patients with Helicobacter pylori-associated gastritis.
por: Bayraktaroğlu, Taner, et al.
Publicado: (2004)

Serum Levels of Soluble Interleukin-2 Receptor in Pulmonary Tuberculosis
por: Choi, Soo Jeon, et al.
Publicado: (1990)

Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves’ orbital fibroblasts
por: Lee, Sung Jun, et al.
Publicado: (2018)

Serum Levels of Interleukin-8 and Soluble Interleukin-6 Receptor in Patients with Stage-I Multiple Myeloma: A Case-Control Study
por: Kohsari, Maryam, et al.
Publicado: (2020)

Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma
por: Suzuki, Kayo, et al.
Publicado: (2022)

Possible Clinical Significance of Serum Soluble Interleukin-2 Receptor Level in Primary Bone Lymphoma: Two Case Reports
por: Yabe, Hiroki, et al.
Publicado: (2011)

Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis
por: Peng, Qing-Lin, et al.
Publicado: (2014)

Regulation of Neuroinflammation: What Role for the Tumor Necrosis Factor-Like Weak Inducer of Apoptosis/Fn14 Pathway?
por: Boulamery, Audrey, et al.
Publicado: (2017)

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Activates Type I Interferon Signals in Lupus Nephritis
por: Xue, Leixi, et al.
Publicado: (2017)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
por: Robak, T, et al.
Publicado: (1998)

Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma
por: Sobjanek, Michal, et al.
Publicado: (2016)

Serum Levels of Interleukin-8 and Tumor Necrosis Factor-alpha in Coal Workers' Pneumoconiosis: One-year Follow-up Study
por: Lee, Jong Seong, et al.
Publicado: (2010)

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.
por: Marino, P., et al.
Publicado: (1990)

Soluble TNF-Like Weak Inducer of Apoptosis as a New Marker in Preeclampsia: A Pilot Clinical Study
por: Yildirim, Zeynep Kayaoglu, et al.
Publicado: (2016)

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.
por: Miles, D. W., et al.
Publicado: (1992)

Baseline interleukin‐10, CD163, and tumor necrosis factor‐like weak inducer of apoptosis (TWEAK) gingival tissue levels in relation to clinical periodontal treatment outcomes: A 12‐week follow‐up study
por: Yilmaz, Mustafa, et al.
Publicado: (2022)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
por: Kaczyński, Tomasz, et al.
Publicado: (2019)

Serum Levels of Tumor Necrosis Factor-α and Interleukins in Children with Congenital Heart Disease
por: Noori, Noor Mohammand, et al.
Publicado: (2017)

Prognostic significance of serum soluble DR5 levels in small-cell lung cancer
por: Wan, Zhenfa, et al.
Publicado: (2019)

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients withelanoma
por: Boyano, M D, et al.
Publicado: (2000)

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Selected Cytokines—Potential Biomarkers in Children with Solitary Functioning Kidney
por: Nosek, Hanna, et al.
Publicado: (2021)

The Significance of Serum Interleukin-8 in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Zhang, Jingxi, et al.
Publicado: (2018)

Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia
por: Sachan, Rekha, et al.
Publicado: (2016)

Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2012)

Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.
por: Nakata, B., et al.
Publicado: (1998)

Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL
por: MITOBE, Yuta, et al.
Publicado: (2023)

Serum levels of interleukin-6 and interleukin-8 as diagnostic markers of acute pyelonephritis in children
por: Mahyar, Abolfazl, et al.
Publicado: (2013)

Reduced soluble TNF-like weak inducer of apoptosis (sTWEAK) and increased frap in postmenopausal women with metabolic syndrome
por: Comim, Fabio Vasconcellos, et al.
Publicado: (2015)

The predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients
por: Yan, Yamin, et al.
Publicado: (2021)

Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer.
por: Scambia, G., et al.
Publicado: (1995)

Maternal and Cord Blood Levels of Serum Amyloid A, C-Reactive Protein, Tumor Necrosis Factor-α, Interleukin-1β, and Interleukin-8 During and After Delivery
por: Cicarelli, Luciane Marzzullo, et al.
Publicado: (2005)

Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate upon Stimulation with TNF-Like Weak Inducer of Apoptosis
por: Wang, Xuening, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2vvaso69al7t22o7tk58kmn8os